Key Points
-
The Gates Foundation Trust has sold its last shares in Microsoft during the first quarter of 2023, concluding a decades-long divestment.
-
The $31.6 billion endowment has also initiated a position in West Pharmaceutical Services, a company based in Exton, Pennsylvania, known for manufacturing containment and delivery systems for injectable drugs.
-
Projected earnings per share for West Pharmaceutical Services are $8.62 in 2026 and $9.55 in 2027, with an annualized growth rate of 14% to 15%, leading to a high forward earnings valuation of 37.6 times.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
